The global Dengue ELISA Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dengue ELISA Kits competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Dengue ELISA Kits are enzyme-linked immunosorbent assay (ELISA) kits specifically designed for the detection of antibodies or antigens related to the Dengue virus in patient samples. Dengue is a mosquito-borne viral infection that can cause a range of symptoms from mild flu-like illness to severe dengue hemorrhagic fever, which can be life-threatening. These ELISA kits help healthcare professionals diagnose Dengue infections by detecting the presence of viral components or antibodies in blood samples, aiding in early detection, management, and monitoring of Dengue cases.

The industry trend for Dengue ELISA Kits is seeing a significant growth due to the increasing global prevalence of Dengue virus infections. As Dengue continues to pose a public health threat in many parts of the world, there is a growing demand for accurate and reliable diagnostic tools like ELISA kits for early detection and surveillance of Dengue outbreaks. Additionally, advancements in technology are leading to the development of more sensitive and specific ELISA kits, further driving the market for Dengue testing products. With ongoing efforts to control Dengue transmission and improve disease management, the demand for Dengue ELISA kits is expected to continue to rise in the industry.

This report delivers a comprehensive overview of the global Dengue ELISA Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dengue ELISA Kits. The Dengue ELISA Kits market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Dengue ELISA Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Dengue ELISA Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Dengue ELISA Kits Market Report

Report Metric	Details
Report Name	Dengue ELISA Kits Market
Segment by Type	IgG IgM
by Application	Hospital Laboratory Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	MyBioSource, BosterBio, DEMEDITEC Diagnostics, Abcam, Abbexa, Eagle Bioscience, IBL, Creative Diagnostics, Abnova Corporation, United States Biological, Creative Biolabs, XpressBio, Aviva Systems Biology, Biorbyt, ELK Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Dengue ELISA Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Dengue ELISA Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Dengue ELISA Kits Market report?

Ans: The main players in the Dengue ELISA Kits Market are MyBioSource, BosterBio, DEMEDITEC Diagnostics, Abcam, Abbexa, Eagle Bioscience, IBL, Creative Diagnostics, Abnova Corporation, United States Biological, Creative Biolabs, XpressBio, Aviva Systems Biology, Biorbyt, ELK Biotechnology

What are the Application segmentation covered in the Dengue ELISA Kits Market report?

Ans: The Applications covered in the Dengue ELISA Kits Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the Dengue ELISA Kits Market report?

Ans: The Types covered in the Dengue ELISA Kits Market report are IgG, IgM

1 Dengue ELISA Kits Market Overview

1.1 Product Definition

1.2 Dengue ELISA Kits by Type

1.2.1 Global Dengue ELISA Kits Market Value by Type: 2025 vs 2032

1.2.2 IgG

1.2.3 IgM

1.3 Dengue ELISA Kits by Application

1.3.1 Global Dengue ELISA Kits Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Laboratory

1.3.4 Others

1.4 Global Dengue ELISA Kits Market Size Estimates and Forecasts

1.4.1 Global Dengue ELISA Kits Revenue 2021–2032

1.4.2 Global Dengue ELISA Kits Sales 2021–2032

1.4.3 Global Dengue ELISA Kits Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Dengue ELISA Kits Market Competition by Manufacturers

2.1 Global Dengue ELISA Kits Sales Market Share by Manufacturers (2021–2026)

2.2 Global Dengue ELISA Kits Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Dengue ELISA Kits Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Dengue ELISA Kits, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Dengue ELISA Kits, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Dengue ELISA Kits, Product Types and Applications

2.7 Global Key Manufacturers of Dengue ELISA Kits, Date of Entry into the Industry

2.8 Global Dengue ELISA Kits Market Competitive Situation and Trends

2.8.1 Global Dengue ELISA Kits Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Dengue ELISA Kits Players Market Share by Revenue

2.8.3 Global Dengue ELISA Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Dengue ELISA Kits Market Scenario by Region

3.1 Global Dengue ELISA Kits Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Dengue ELISA Kits Sales by Region: 2021–2032

3.2.1 Global Dengue ELISA Kits Sales by Region: 2021–2026

3.2.2 Global Dengue ELISA Kits Sales by Region: 2027–2032

3.3 Global Dengue ELISA Kits Revenue by Region: 2021–2032

3.3.1 Global Dengue ELISA Kits Revenue by Region: 2021–2026

3.3.2 Global Dengue ELISA Kits Revenue by Region: 2027–2032

3.4 North America Dengue ELISA Kits Market Facts & Figures by Country

3.4.1 North America Dengue ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Dengue ELISA Kits Sales by Country (2021–2032)

3.4.3 North America Dengue ELISA Kits Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Dengue ELISA Kits Market Facts & Figures by Country

3.5.1 Europe Dengue ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Dengue ELISA Kits Sales by Country (2021–2032)

3.5.3 Europe Dengue ELISA Kits Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Dengue ELISA Kits Market Facts & Figures by Region

3.6.1 Asia Pacific Dengue ELISA Kits Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Dengue ELISA Kits Sales by Region (2021–2032)

3.6.3 Asia Pacific Dengue ELISA Kits Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Dengue ELISA Kits Market Facts & Figures by Country

3.7.1 Latin America Dengue ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Dengue ELISA Kits Sales by Country (2021–2032)

3.7.3 Latin America Dengue ELISA Kits Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Dengue ELISA Kits Market Facts & Figures by Country

3.8.1 Middle East and Africa Dengue ELISA Kits Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Dengue ELISA Kits Sales by Country (2021–2032)

3.8.3 Middle East and Africa Dengue ELISA Kits Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Dengue ELISA Kits Sales by Type (2021–2032)

4.1.1 Global Dengue ELISA Kits Sales by Type (2021–2026)

4.1.2 Global Dengue ELISA Kits Sales by Type (2027–2032)

4.1.3 Global Dengue ELISA Kits Sales Market Share by Type (2021–2032)

4.2 Global Dengue ELISA Kits Revenue by Type (2021–2032)

4.2.1 Global Dengue ELISA Kits Revenue by Type (2021–2026)

4.2.2 Global Dengue ELISA Kits Revenue by Type (2027–2032)

4.2.3 Global Dengue ELISA Kits Revenue Market Share by Type (2021–2032)

4.3 Global Dengue ELISA Kits Price by Type (2021–2032)

5 Segment by Application

5.1 Global Dengue ELISA Kits Sales by Application (2021–2032)

5.1.1 Global Dengue ELISA Kits Sales by Application (2021–2026)

5.1.2 Global Dengue ELISA Kits Sales by Application (2027–2032)

5.1.3 Global Dengue ELISA Kits Sales Market Share by Application (2021–2032)

5.2 Global Dengue ELISA Kits Revenue by Application (2021–2032)

5.2.1 Global Dengue ELISA Kits Revenue by Application (2021–2026)

5.2.2 Global Dengue ELISA Kits Revenue by Application (2027–2032)

5.2.3 Global Dengue ELISA Kits Revenue Market Share by Application (2021–2032)

5.3 Global Dengue ELISA Kits Price by Application (2021–2032)

6 Key Companies Profiled

6.1 MyBioSource

6.1.1 MyBioSource Company Information

6.1.2 MyBioSource Description and Business Overview

6.1.3 MyBioSource Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 MyBioSource Dengue ELISA Kits Product Portfolio

6.1.5 MyBioSource Recent Developments/Updates

6.2 BosterBio

6.2.1 BosterBio Company Information

6.2.2 BosterBio Description and Business Overview

6.2.3 BosterBio Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 BosterBio Dengue ELISA Kits Product Portfolio

6.2.5 BosterBio Recent Developments/Updates

6.3 DEMEDITEC Diagnostics

6.3.1 DEMEDITEC Diagnostics Company Information

6.3.2 DEMEDITEC Diagnostics Description and Business Overview

6.3.3 DEMEDITEC Diagnostics Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 DEMEDITEC Diagnostics Dengue ELISA Kits Product Portfolio

6.3.5 DEMEDITEC Diagnostics Recent Developments/Updates

6.4 Abcam

6.4.1 Abcam Company Information

6.4.2 Abcam Description and Business Overview

6.4.3 Abcam Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Abcam Dengue ELISA Kits Product Portfolio

6.4.5 Abcam Recent Developments/Updates

6.5 Abbexa

6.5.1 Abbexa Company Information

6.5.2 Abbexa Description and Business Overview

6.5.3 Abbexa Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Abbexa Dengue ELISA Kits Product Portfolio

6.5.5 Abbexa Recent Developments/Updates

6.6 Eagle Bioscience

6.6.1 Eagle Bioscience Company Information

6.6.2 Eagle Bioscience Description and Business Overview

6.6.3 Eagle Bioscience Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Eagle Bioscience Dengue ELISA Kits Product Portfolio

6.6.5 Eagle Bioscience Recent Developments/Updates

6.7 IBL

6.7.1 IBL Company Information

6.7.2 IBL Description and Business Overview

6.7.3 IBL Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 IBL Dengue ELISA Kits Product Portfolio

6.7.5 IBL Recent Developments/Updates

6.8 Creative Diagnostics

6.8.1 Creative Diagnostics Company Information

6.8.2 Creative Diagnostics Description and Business Overview

6.8.3 Creative Diagnostics Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Creative Diagnostics Dengue ELISA Kits Product Portfolio

6.8.5 Creative Diagnostics Recent Developments/Updates

6.9 Abnova Corporation

6.9.1 Abnova Corporation Company Information

6.9.2 Abnova Corporation Description and Business Overview

6.9.3 Abnova Corporation Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Abnova Corporation Dengue ELISA Kits Product Portfolio

6.9.5 Abnova Corporation Recent Developments/Updates

6.10 United States Biological

6.10.1 United States Biological Company Information

6.10.2 United States Biological Description and Business Overview

6.10.3 United States Biological Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 United States Biological Dengue ELISA Kits Product Portfolio

6.10.5 United States Biological Recent Developments/Updates

6.11 Creative Biolabs

6.11.1 Creative Biolabs Company Information

6.11.2 Creative Biolabs Description and Business Overview

6.11.3 Creative Biolabs Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Creative Biolabs Dengue ELISA Kits Product Portfolio

6.11.5 Creative Biolabs Recent Developments/Updates

6.12 XpressBio

6.12.1 XpressBio Company Information

6.12.2 XpressBio Description and Business Overview

6.12.3 XpressBio Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 XpressBio Dengue ELISA Kits Product Portfolio

6.12.5 XpressBio Recent Developments/Updates

6.13 Aviva Systems Biology

6.13.1 Aviva Systems Biology Company Information

6.13.2 Aviva Systems Biology Description and Business Overview

6.13.3 Aviva Systems Biology Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Aviva Systems Biology Dengue ELISA Kits Product Portfolio

6.13.5 Aviva Systems Biology Recent Developments/Updates

6.14 Biorbyt

6.14.1 Biorbyt Company Information

6.14.2 Biorbyt Description and Business Overview

6.14.3 Biorbyt Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Biorbyt Dengue ELISA Kits Product Portfolio

6.14.5 Biorbyt Recent Developments/Updates

6.15 ELK Biotechnology

6.15.1 ELK Biotechnology Company Information

6.15.2 ELK Biotechnology Description and Business Overview

6.15.3 ELK Biotechnology Dengue ELISA Kits Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 ELK Biotechnology Dengue ELISA Kits Product Portfolio

6.15.5 ELK Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Dengue ELISA Kits Industry Chain Analysis

7.2 Dengue ELISA Kits Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Dengue ELISA Kits Production Mode & Process Analysis

7.4 Dengue ELISA Kits Sales and Marketing

7.4.1 Dengue ELISA Kits Sales Channels

7.4.2 Dengue ELISA Kits Distributors

7.5 Dengue ELISA Kits Customer Analysis

8 Dengue ELISA Kits Market Dynamics

8.1 Dengue ELISA Kits Industry Trends

8.2 Dengue ELISA Kits Market Drivers

8.3 Dengue ELISA Kits Market Challenges

8.4 Dengue ELISA Kits Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

MyBioSource

BosterBio

Demeditec Diagnostics

United States Biological

Creative-Biolabs

XpressBio

Aviva Systems Biology

Biorbyt

ELK Biotechnology

List of Tables

Table 1. Global Dengue ELISA Kits Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Dengue ELISA Kits Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Dengue ELISA Kits Market Competitive Situation by Manufacturers in 2025

Table 4. Global Dengue ELISA Kits Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Dengue ELISA Kits Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Dengue ELISA Kits Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Dengue ELISA Kits Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Dengue ELISA Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Dengue ELISA Kits, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Dengue ELISA Kits, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Dengue ELISA Kits, Product Types and Applications

Table 12. Global Key Manufacturers of Dengue ELISA Kits, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Dengue ELISA Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dengue ELISA Kits Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Dengue ELISA Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Dengue ELISA Kits Sales by Region (K Units), 2021–2026

Table 18. Global Dengue ELISA Kits Sales Market Share by Region (2021–2026)

Table 19. Global Dengue ELISA Kits Sales by Region (K Units), 2027–2032

Table 20. Global Dengue ELISA Kits Sales Market Share by Region (2027–2032)

Table 21. Global Dengue ELISA Kits Revenue by Region (US$ Million), 2021–2026

Table 22. Global Dengue ELISA Kits Revenue Market Share by Region (2021–2026)

Table 23. Global Dengue ELISA Kits Revenue by Region (US$ Million), 2027–2032

Table 24. Global Dengue ELISA Kits Revenue Market Share by Region (2027–2032)

Table 25. North America Dengue ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Dengue ELISA Kits Sales by Country (K Units), 2021–2026

Table 27. North America Dengue ELISA Kits Sales by Country (K Units), 2027–2032

Table 28. North America Dengue ELISA Kits Revenue by Country (US$ Million), 2021–2026

Table 29. North America Dengue ELISA Kits Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Dengue ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Dengue ELISA Kits Sales by Country (K Units), 2021–2026

Table 32. Europe Dengue ELISA Kits Sales by Country (K Units), 2027–2032

Table 33. Europe Dengue ELISA Kits Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Dengue ELISA Kits Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Dengue ELISA Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Dengue ELISA Kits Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Dengue ELISA Kits Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Dengue ELISA Kits Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Dengue ELISA Kits Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Dengue ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Dengue ELISA Kits Sales by Country (K Units), 2021–2026

Table 42. Latin America Dengue ELISA Kits Sales by Country (K Units), 2027–2032

Table 43. Latin America Dengue ELISA Kits Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Dengue ELISA Kits Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Dengue ELISA Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Dengue ELISA Kits Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Dengue ELISA Kits Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Dengue ELISA Kits Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Dengue ELISA Kits Revenue by Country (US$ Million), 2027–2032

Table 50. Global Dengue ELISA Kits Sales (K Units) by Type (2021–2026)

Table 51. Global Dengue ELISA Kits Sales (K Units) by Type (2027–2032)

Table 52. Global Dengue ELISA Kits Sales Market Share by Type (2021–2026)

Table 53. Global Dengue ELISA Kits Sales Market Share by Type (2027–2032)

Table 54. Global Dengue ELISA Kits Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Dengue ELISA Kits Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Dengue ELISA Kits Revenue Market Share by Type (2021–2026)

Table 57. Global Dengue ELISA Kits Revenue Market Share by Type (2027–2032)

Table 58. Global Dengue ELISA Kits Price (US$/Unit) by Type (2021–2026)

Table 59. Global Dengue ELISA Kits Price (US$/Unit) by Type (2027–2032)

Table 60. Global Dengue ELISA Kits Sales (K Units) by Application (2021–2026)

Table 61. Global Dengue ELISA Kits Sales (K Units) by Application (2027–2032)

Table 62. Global Dengue ELISA Kits Sales Market Share by Application (2021–2026)

Table 63. Global Dengue ELISA Kits Sales Market Share by Application (2027–2032)

Table 64. Global Dengue ELISA Kits Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Dengue ELISA Kits Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Dengue ELISA Kits Revenue Market Share by Application (2021–2026)

Table 67. Global Dengue ELISA Kits Revenue Market Share by Application (2027–2032)

Table 68. Global Dengue ELISA Kits Price (US$/Unit) by Application (2021–2026)

Table 69. Global Dengue ELISA Kits Price (US$/Unit) by Application (2027–2032)

Table 70. MyBioSource Company Information

Table 71. MyBioSource Description and Business Overview

Table 72. MyBioSource Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. MyBioSource Dengue ELISA Kits Product

Table 74. MyBioSource Recent Developments/Updates

Table 75. BosterBio Company Information

Table 76. BosterBio Description and Business Overview

Table 77. BosterBio Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. BosterBio Dengue ELISA Kits Product

Table 79. BosterBio Recent Developments/Updates

Table 80. DEMEDITEC Diagnostics Company Information

Table 81. DEMEDITEC Diagnostics Description and Business Overview

Table 82. DEMEDITEC Diagnostics Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. DEMEDITEC Diagnostics Dengue ELISA Kits Product

Table 84. DEMEDITEC Diagnostics Recent Developments/Updates

Table 85. Abcam Company Information

Table 86. Abcam Description and Business Overview

Table 87. Abcam Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Abcam Dengue ELISA Kits Product

Table 89. Abcam Recent Developments/Updates

Table 90. Abbexa Company Information

Table 91. Abbexa Description and Business Overview

Table 92. Abbexa Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Abbexa Dengue ELISA Kits Product

Table 94. Abbexa Recent Developments/Updates

Table 95. Eagle Bioscience Company Information

Table 96. Eagle Bioscience Description and Business Overview

Table 97. Eagle Bioscience Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Eagle Bioscience Dengue ELISA Kits Product

Table 99. Eagle Bioscience Recent Developments/Updates

Table 100. IBL Company Information

Table 101. IBL Description and Business Overview

Table 102. IBL Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. IBL Dengue ELISA Kits Product

Table 104. IBL Recent Developments/Updates

Table 105. Creative Diagnostics Company Information

Table 106. Creative Diagnostics Description and Business Overview

Table 107. Creative Diagnostics Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Creative Diagnostics Dengue ELISA Kits Product

Table 109. Creative Diagnostics Recent Developments/Updates

Table 110. Abnova Corporation Company Information

Table 111. Abnova Corporation Description and Business Overview

Table 112. Abnova Corporation Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Abnova Corporation Dengue ELISA Kits Product

Table 114. Abnova Corporation Recent Developments/Updates

Table 115. United States Biological Company Information

Table 116. United States Biological Description and Business Overview

Table 117. United States Biological Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 118. United States Biological Dengue ELISA Kits Product

Table 119. United States Biological Recent Developments/Updates

Table 120. Creative Biolabs Company Information

Table 121. Creative Biolabs Description and Business Overview

Table 122. Creative Biolabs Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 123. Creative Biolabs Dengue ELISA Kits Product

Table 124. Creative Biolabs Recent Developments/Updates

Table 125. XpressBio Company Information

Table 126. XpressBio Description and Business Overview

Table 127. XpressBio Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 128. XpressBio Dengue ELISA Kits Product

Table 129. XpressBio Recent Developments/Updates

Table 130. Aviva Systems Biology Company Information

Table 131. Aviva Systems Biology Description and Business Overview

Table 132. Aviva Systems Biology Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 133. Aviva Systems Biology Dengue ELISA Kits Product

Table 134. Aviva Systems Biology Recent Developments/Updates

Table 135. Biorbyt Company Information

Table 136. Biorbyt Description and Business Overview

Table 137. Biorbyt Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 138. Biorbyt Dengue ELISA Kits Product

Table 139. Biorbyt Recent Developments/Updates

Table 140. ELK Biotechnology Company Information

Table 141. ELK Biotechnology Description and Business Overview

Table 142. ELK Biotechnology Dengue ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 143. ELK Biotechnology Dengue ELISA Kits Product

Table 144. ELK Biotechnology Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Dengue ELISA Kits Distributors List

Table 148. Dengue ELISA Kits Customers List

Table 149. Dengue ELISA Kits Market Trends

Table 150. Dengue ELISA Kits Market Drivers

Table 151. Dengue ELISA Kits Market Challenges

Table 152. Dengue ELISA Kits Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Dengue ELISA Kits

Figure 2. Global Dengue ELISA Kits Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Dengue ELISA Kits Market Share by Type: 2025 & 2032

Figure 4. IgG Product Picture

Figure 5. IgM Product Picture

Figure 6. Global Dengue ELISA Kits Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Dengue ELISA Kits Market Share by Application: 2025 & 2032

Figure 8. Hospital

Figure 9. Laboratory

Figure 10. Others

Figure 11. Global Dengue ELISA Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Dengue ELISA Kits Market Size (US$ Million), 2021–2032

Figure 13. Global Dengue ELISA Kits Sales (K Units), 2021–2032

Figure 14. Global Dengue ELISA Kits Average Price (US$/Unit), 2021–2032

Figure 15. Dengue ELISA Kits Report Years Considered

Figure 16. Dengue ELISA Kits Sales Share by Manufacturers in 2025

Figure 17. Global Dengue ELISA Kits Revenue Share by Manufacturers in 2025

Figure 18. Top 5 and Top 10 Global Dengue ELISA Kits Players: Market Share by Revenue in Dengue ELISA Kits in 2025

Figure 19. Dengue ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Global Dengue ELISA Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 21. North America Dengue ELISA Kits Sales Market Share by Country (2021–2032)

Figure 22. North America Dengue ELISA Kits Revenue Market Share by Country (2021–2032)

Figure 23. United States Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Canada Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Europe Dengue ELISA Kits Sales Market Share by Country (2021–2032)

Figure 26. Europe Dengue ELISA Kits Revenue Market Share by Country (2021–2032)

Figure 27. Germany Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. France Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. U.K. Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Italy Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Russia Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Asia Pacific Dengue ELISA Kits Sales Market Share by Region (2021–2032)

Figure 33. Asia Pacific Dengue ELISA Kits Revenue Market Share by Region (2021–2032)

Figure 34. China Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Japan Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. South Korea Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. India Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Australia Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. China Taiwan Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Southeast Asia Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Latin America Dengue ELISA Kits Sales Market Share by Country (2021–2032)

Figure 42. Latin America Dengue ELISA Kits Revenue Market Share by Country (2021–2032)

Figure 43. Mexico Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Brazil Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Argentina Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Colombia Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Middle East and Africa Dengue ELISA Kits Sales Market Share by Country (2021–2032)

Figure 48. Middle East and Africa Dengue ELISA Kits Revenue Market Share by Country (2021–2032)

Figure 49. Turkey Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Saudi Arabia Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. UAE Dengue ELISA Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Global Sales Market Share of Dengue ELISA Kits by Type (2021–2032)

Figure 53. Global Revenue Market Share of Dengue ELISA Kits by Type (2021–2032)

Figure 54. Global Dengue ELISA Kits Price (US$/Unit) by Type (2021–2032)

Figure 55. Global Sales Market Share of Dengue ELISA Kits by Application (2021–2032)

Figure 56. Global Revenue Market Share of Dengue ELISA Kits by Application (2021–2032)

Figure 57. Global Dengue ELISA Kits Price (US$/Unit) by Application (2021–2032)

Figure 58. Dengue ELISA Kits Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions